1194. Screening for suicide risk in adolescents, adults, and older adults in primary care: U.S. Preventive Services Task Force recommendation statement.
Update of the 2004 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for suicide risk.
1195. Biological agents for moderately to severely active ulcerative colitis: a systematic review and network meta-analysis.
作者: Silvio Danese.;Gionata Fiorino.;Laurent Peyrin-Biroulet.;Ersilia Lucenteforte.;Gianni Virgili.;Lorenzo Moja.;Stefanos Bonovas.
来源: Ann Intern Med. 2014年160卷10期704-11页
Biological agents are emerging treatment options for the management of ulcerative colitis (UC).
1196. Health and economic benefits of early vaccination and nonpharmaceutical interventions for a human influenza A (H7N9) pandemic: a modeling study.
作者: Nayer Khazeni.;David W Hutton.;Cassandra I F Collins.;Alan M Garber.;Douglas K Owens.
来源: Ann Intern Med. 2014年160卷10期684-94页
Vaccination for the 2009 pandemic did not occur until late in the outbreak, which limited its benefits. Influenza A (H7N9) is causing increasing morbidity and mortality in China, and researchers have modified the A (H5N1) virus to transmit via aerosol, which again heightens concerns about pandemic influenza preparedness.
1197. Cost-effectiveness of the children's oncology group long-term follow-up screening guidelines for childhood cancer survivors at risk for treatment-related heart failure.
作者: F Lennie Wong.;Smita Bhatia.;Wendy Landier.;Liton Francisco.;Wendy Leisenring.;Melissa M Hudson.;Gregory T Armstrong.;Ann Mertens.;Marilyn Stovall.;Leslie L Robison.;Gary H Lyman.;Steven E Lipshultz.;Saro H Armenian.
来源: Ann Intern Med. 2014年160卷10期672-83页
Childhood cancer survivors treated with anthracyclines are at high risk for asymptomatic left ventricular dysfunction (ALVD), subsequent heart failure, and death. The consensus-based Children's Oncology Group (COG) Long-Term Follow-up Guidelines recommend lifetime echocardiographic screening for ALVD.
1198. Routine echocardiography screening for asymptomatic left ventricular dysfunction in childhood cancer survivors: a model-based estimation of the clinical and economic effects.
Childhood cancer survivors treated with cardiotoxic therapies are recommended to have routine cardiac assessment every 1 to 5 years, but the long-term benefits are uncertain.
|